Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
TCM+ Routine Therapy
The First People's Hospital of Lianyungang
Proteinuria
1 trial -
Tegoprazan-amoxicillin dual therapy
The First People's Hospital of Lianyungang
Helicobacter Pylori Infection
1 trial -
Ticagrelor monotherapy
The First People's Hospital of Lianyungang
Intracranial Aneurysm
1 trial -
To withdraw NSAIDs therapy
The First People's Hospital of Lianyungang
Axial Spondyloarthritis
1 trial -
Western therapy
Chinese University of Hong Kong
Hand, Foot and Mouth Disease
1 trial -
anti-PD-1 / PD-L1 monoclonal antibody and chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Effect Increased
1 trial -
bismuth-containing quadral therapy based on antibiotic susceptibility
Shandong University
Helicobacter Pylori
1 trial -
brachytherapy
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
chemotherapy
United Therapeutics Europe Ltd
Malignant Mesothelioma
1 trial -
chemotherapy plus TCM 1&ICIs plusTCM2
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
conventional radiotherapy 74 Gy delivered in 37 fractions
United Therapeutics Europe Ltd
Prostate Cancer
1 trial -
only antiemetic (Ramosetron, Tropisetron and dexamethasone)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Chemotherapy-induced Nausea and Vomiting
1 trial -
postoperative adjuvant chemotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Small-cell Lung Cancer
1 trial -
radiochemotherapy 1
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Non Small Cell Lung Cancer
1 trial -
simultaneous integrated boost intensity-modulated radiation therapy combined with ripretinib
The First People's Hospital of Lianyungang
Gastrointestinal Stromal Tumors
1 trial -
stereotactic body radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Prostate Cancer
1 trial -
steroid therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Sudden Hearing Loss
1 trial -
zoledronate therapy
United Therapeutics Europe Ltd
Prostate Cancer
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources